MED12 and Miyoshi myopathy: This analysis revealed that PC1 segregates bulk tissues from cells (Fig. S4A) and, more importantly, MM SCs treated with CCT251545 for 3.5d were closer to MED12 mutant tumors than MED12 G44N UtSMCs (Fig. S4B).